Because SARS-CoV-2 is present in respiratory secretions and spreads through aerosolized particles, all types of in-person sexual activity “probably” carry some risk for transmitting the virus that causes COVID-19, according to three doctors affiliated with Massachusetts General Hospital in Boston.
Abstinence is the lowest risk approach to sex during the pandemic, and masturbation is additional safe recommendation for patients, according to Jack Turban, M.D., M.H.S., Alex S. Keuroghlian, M.D., M.P.H. and Kenneth Mayer, M.D., writing in yesterday’s Annals of Internal Medicine. Keuroghlian and Mayer are also affliated with the Fenway Instittue in Boston.
They note, though, the lack of data about sexual transmission of SARS-CoV-2 in their “ideas and opinions” piece for the journal published by the American College of Physicians in Philadelphia. Turban, Keuroghlian, and Mayer reference two small studies that showed no detectable SARS-CoV-2 in semen or vaginal secretions, although they point to a third study that found evidence of the virus in 16% (6 of 38) of semen samples. The authors of that study, which was published on May 7 in the JAMA Network Open, say that “even if the virus cannot replicate in the male reproductive system, it may persist, possibly resulting from the privileged immunity of testes.”
Whether evidence of the presence of SARS-CoV-2 in semen means the infection can be transmitted vai semen is unknown, but the authors say “it would be prudent o consider semen as potentially infectious.” Their advice about SARS-Cov-2 in urine is the similar.
The trio of physicians also say that patients can be counseled to engage in sexual activity with partners remotely via the telephone or video chats but should also be warned about the risk of partners taking screenshots of conversation.
For those for whom abstinence from in-person sexual activity is “not achievable,” Turban, Keuroghlian and Mayer suggest that having sex with someone with whom they are self-quarantining is the best approach.
They also mention that antibody tests may play an important role in evaluating COVID-19 sexual risks and safe sex practices as it has with HIV. People who test positive for antibodies against SARS-CoV-2 may have relative immunity against contracting an infection. That immunity may, therefore, allow for “serosorting of individuals for sexual activity.” Safe sex, with respect to SARS-CoV-2 transmission, may be possible among those have tested positive for the antibodies, according to Turban, Keuroghlian and Mayer.
AstraZeneca, Daiichi Sankyo Submit New BLA for Datopotamab in Lung Cancer
November 12th 2024After feedback from the FDA, the companies have voluntarily withdrawn the previous biologics licensing application for datopotamab deruxtecan for patients with advanced or metastatic nonsquamous non-small cell lung cancer.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Breast Cancer Patients Desire Early, Frequent Financial Screening
November 11th 2024Current financial screening procedures in the United States may need to change, according to recent research done by Laila Gharzai, M.D., LLM, from the Department of Radiation Oncology at Northwestern University.
Read More
In our latest "Meet the Board" podcast episode, Managed Healthcare Executive Editors caught up with editorial advisory board member, Eric Hunter, CEO of CareOregon, to discuss a number of topics, one including the merger that never closed with SCAN Health Plan due to local opposition from Oregonians.
Listen
The Takeaway From Study of Midlife MS Patients: Don't Stop Disease-Modifying Therapy
Published: November 11th 2024 | Updated: November 11th 2024People with multiple sclerosis (MS) often stop taking disease-modifying therapy as they transition from relapsing-remitting MS to secondary progressive MS. This study shows that people who stop stop disease-modifying therapy have higher hospitalization rates and more visits to the emergency room.
Read More